The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; AstraZeneca; Celldex; Eisai; Pfizer; Puma Biotechnology
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Covance/Bayer (Inst); Incyte (Inst); Lilly (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).
 
Rachel A. Freedman
Research Funding - Eisai (Inst); Genentech (Inst); Puma Biotechnology (Inst)
 
Rebecca Sue Gelman
No Relationships to Disclose
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Honoraria - Agendia; Genentech; Genentech (I); Nektar; Pfizer (I)
Consulting or Advisory Role - Genentech (I)
Speakers' Bureau - Agendia; Genentech (I); Pfizer (I)
Research Funding - Celldex (Inst); Galena Biopharma (Inst); Genentech (Inst); Lilly (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; GERON; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Geron (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Oncothyreon (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
 
Kimberly L. Blackwell
Consulting or Advisory Role - Advaxis; Amgen; Amgen; Bayer; Celgene; Coherus Biosciences; Eisai; G1 Therapeutics; Genentech; Incyte; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz; Spectrum Pharmaceuticals
Research Funding - Genentech (Inst); Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Advaxis; Amgen; Celgene; Coherus Biosciences; Eisai; Genentech; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz
 
Roisin M. Connolly
Research Funding - Clovis Oncology (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Novartis
 
Polly Ann Niravath
No Relationships to Disclose
 
Catherine H. Van Poznak
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Shannon Puhalla
No Relationships to Disclose
 
Sarah Farooq
Employment - Takeda (I)
Stock and Other Ownership Interests - AVEO (I); Novartis (I); Orexigen (I); Seres Therapeutics (I); ZIOPHARM Oncology (I)
 
Anne Cropp
No Relationships to Disclose
 
Christine M Cotter
No Relationships to Disclose
 
Minetta C. Liu
Research Funding - Celgene (Inst); Eisai (Inst); GRAIL (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Veridex (Inst)
Travel, Accommodations, Expenses - Celgene; GRAIL; Merck
 
Ian E. Krop
Employment - AMAG Pharmaceuticals (I)
Leadership - AMAG Pharmaceuticals (I)
Stock and Other Ownership Interests - AMAG Pharmaceuticals (I)
Research Funding - Genentech
 
Julie R. Nangia
No Relationships to Disclose
 
Nadine M. Tung
Research Funding - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Ambry Genetics (Inst)
 
Antonio C. Wolff
Consulting or Advisory Role - Pfizer
Research Funding - Myriad Genetics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Leap Therapeutics; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; GlaxoSmithKline; Kadmon; Novartis; Oncothyreon